UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bipolar disorder and metabolic syndrome: An international perspective

Journal of affective disorders, 2010-11, Vol.126 (3), p.366-387

2010

Volltextzugriff (PDF)

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

Bipolar disorders, 2010-06, Vol.12 (4), p.404-413

2010

Volltextzugriff (PDF)

Managing the side effects associated with commonly used treatments for bipolar depression

Journal of affective disorders, 2014-12, Vol.169, p.S34-S44

Kemp, David E

2014

Volltextzugriff (PDF)

Design and Implementation of a Digitally Enabled Care Pathway to Improve Management of Depression in a Large Health Care System: Protocol for the Implementation of a Patient Care Platform

JMIR research protocols, 2023-06, Vol.12, p.e43788-e43788

2023

Volltextzugriff (PDF)

Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation

The international journal of neuropsychopharmacology, 2008-02, Vol.11 (1), p.119-130

2008

Volltextzugriff (PDF)

User-Centered Design of a Digitally Enabled Care Pathway in a Large Health System: Qualitative Interview Study

JMIR human factors, 2023-07, Vol.10, p.e42768-e42768

2023

Volltextzugriff (PDF)

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

The journal of clinical psychiatry, 2009-08, Vol.70 (8), p.1078-1090

2009

Volltextzugriff (PDF)

Double-blind, placebo-controlled trial of pioglitazone for bipolar depression

Journal of affective disorders, 2019-02, Vol.245, p.957-964

2019

Volltextzugriff (PDF)

PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression

CNS drugs, 2014-06, Vol.28 (6), p.571-581

2014

Volltextzugriff (PDF)

Cardiometabolic Health in Bipolar Disorder

Psychiatric annals, 2012-05, Vol.42 (5), p.179-183

2012

Volltextzugriff (PDF)

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review

Journal of clinical psychopharmacology, 2008-04, Vol.28 (2), p.203-209

2008

Volltextzugriff (PDF)

Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity

Journal of affective disorders, 2012-02, Vol.136 (3), p.1164-1173

2012

Volltextzugriff (PDF)

A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder

Journal of clinical psychopharmacology, 2009-06, Vol.29 (3), p.291-295

2009

Volltextzugriff (PDF)

Second-generation antipsychotics in major depressive disorder: update and clinical perspective

Current opinion in psychiatry, 2011-01, Vol.24 (1), p.10-17

2011

Volltextzugriff (PDF)

Communication of Potential Benefits and Harm to Patients and Payers in Psychiatry: A Review and Commentary

Clinical therapeutics, 2011-12, Vol.33 (12), p.B62-B76

2011

Volltextzugriff (PDF)

Differentiating bipolar disorders from major depressive disorders: treatment implications

Annals of clinical psychiatry, 2007-10, Vol.19 (4), p.305-312

2007

Volltextzugriff (PDF)

Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder

The journal of clinical psychiatry, 2014-03, Vol.75 (3), p.238-245

2014

Volltextzugriff (PDF)

Antidepressant Response Associated With Pioglitazone: Support for an Overlapping Pathophysiology Between Major Depression and Metabolic Syndrome

The American journal of psychiatry, 2009-05, Vol.166 (5), p.619-619

2009

Volltextzugriff (PDF)

Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial

The journal of clinical psychiatry, 2014-10, Vol.75 (10), p.1062-1068

2014

Volltextzugriff (PDF)

Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder

Journal of affective disorders, 2013-11, Vol.151 (2), p.722-727

2013

Volltextzugriff (PDF)

Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics

The journal of clinical psychiatry, 2011-08, Vol.72 (8), p.1063-1071

2011

Volltextzugriff (PDF)

Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorder

Journal of psychiatric research, 2015-01, Vol.60, p.117-124

2015

Volltextzugriff (PDF)

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders

Annals of clinical psychiatry, 2012-02, Vol.24 (1), p.69

2012

Volltextzugriff (PDF)

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence

The journal of clinical psychiatry, 2009-01, Vol.70 (1), p.113-121

2009

Volltextzugriff (PDF)

1 – 25 von 857

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(782)
Mit Volltextzugriff
(691)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(579)
Life Sciences & Biomedicine
(468)
Humans
(376)
Male
(207)
Female
(204)
Animals
(171)
Biological And Medical Sciences
(160)
Adult
(144)
Middle Aged
(127)
Medical Sciences
(122)
Aged
(78)
Biochemistry & Molecular Biology
(77)
Fundamental And Applied Biological Sciences. Psychology
(66)
Psychiatry
(66)
Physical Sciences
(65)
Mice
(64)
Adolescent
(59)
Science & Technology - Other Topics
(55)
Multidisciplinary Sciences
(54)
Bipolar Disorder - Drug Therapy
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Bipolar disorder and metabolic syndrome: An international perspective

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

Managing the side effects associated with commonly used treatments for bipolar depression

Design and Implementation of a Digitally Enabled Care Pathway to Improve Management of Depression in a Large Health Care System: Protocol for the Implementation of a Patient Care Platform

Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation

User-Centered Design of a Digitally Enabled Care Pathway in a Large Health System: Qualitative Interview Study

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

Double-blind, placebo-controlled trial of pioglitazone for bipolar depression

PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression

Cardiometabolic Health in Bipolar Disorder

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review

Use of insulin sensitizers for the treatment of major depressive disorder: A pilot study of pioglitazone for major depression accompanied by abdominal obesity

A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder

Second-generation antipsychotics in major depressive disorder: update and clinical perspective

Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)

Communication of Potential Benefits and Harm to Patients and Payers in Psychiatry: A Review and Commentary

Differentiating bipolar disorders from major depressive disorders: treatment implications

Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder

Antidepressant Response Associated With Pioglitazone: Support for an Overlapping Pathophysiology Between Major Depression and Metabolic Syndrome

Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial

Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder

Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics

Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorder

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence

Suchergebnisse filtern